Skip to main content
logo
TWi Biotechnology, Inc. (TPEX:6610)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
40.95
+0.40 (0.99%)
Sep 8, 2026, 1:59 PM CST

TWi Biotechnology Financials Overview

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
-----66.4
Revenue Growth
-----5228.81%
Gross Profit
-----65.48
Operating Income
-360.64-357.02-417.32-169.56-90.18-15.3
Net Income
-299.4-202.37-164.81-170.68-76.18-15.3
Earnings Per Share
-2.22-1.84-2.67-2.33-1.13-0.23
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
110.85263.72356.46323.69160.4223.14
Total Debt
1.62.9515.67.972.535.02
Net Cash (Debt)
109.25260.77340.86315.72157.87218.11
Net Cash Growth
-58.10%-23.50%7.96%99.98%-27.62%6.48%
Net Cash Per Share
0.531.341.864.312.343.23

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-284.29-286.99-461.72-134.22-60.24-34.46
Capital Expenditures
-0.39-0.41-0.31---0.23
Free Cash Flow
-284.68-287.4-462.03-134.22-60.24-34.69
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-----98.63%
Operating Margin
------23.04%
Pretax Margin
------23.04%
Profit Margin
------23.04%
FCF Margin
------52.24%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
-----16.40